COMPANY
Baxter Healthcare Corporation
Baxter Healthcare Corporation: US labeler, recalling firm for Daptomycin, Vancomycin, Vasopressin, as stated by public registers.
US LABELER
Lists a finished product with FDA (NDC directory); can be a maker, repackager or distributor.
| Daptomycin | Daptomycin in Sodium Chloride, NDA Regulator openFDA |
|---|---|
| Daptomycin | DAPZURA RT, NDA Regulator openFDA |
| Vancomycin | VANCOMYCIN HYDROCHLORIDE, NDA Regulator openFDA |
| Vasopressin | Vasopressin in 0.9% Sodium Chloride, NDA Regulator openFDA |
RECALLING FIRM
Recalled a product naming the peptide (FDA enforcement report).
| Daptomycin | Class II recall, Ongoing, 2026-09-09 Regulator openFDA |
|---|---|
| Vancomycin | Class II recall, Ongoing, 2026-09-09 Regulator openFDA |
| Vasopressin | Class II recall, Ongoing, 2026-09-09 Regulator openFDA |
What a register states, not an endorsement or an accusation by this site. All companies.
WEEKLY
Register Watch, weekly
New trials, approvals and enforcement actions. One email a week.